Figure 5
Figure 5. Transient ChIP analysis using Wt and Mt MYL9 promoter (−691/+4)-luciferase reporter constructs in PMA-treated HEL cells. Cells were transfected with reporter constructs containing WtMYL9 promoter region (−691/+4) with RUNX1 sites (open boxes) or with RUNX1 sites I-IV individually mutated (filled boxes) as shown. ChIP was performed on these cells using anti-RUNX1 antibody or control IgG. PCR was performed using primers (shown by arrows), where the forward primer was specific to the MYL9 region (−140/−107) and the reverse primer was specific to the luciferase gene (Panel A; MYL9-luciferase plasmid). As a control, PCR was performed using a second set of primers (not shown) where both primers were specific to the endogenous MYL9 sequence (Panel B; endogenous MYL9). In addition, GAPDH was amplified (C). Each panel shows PCR products obtained from amplification of IgG- or anti-RUNX1 antibody-immunoprecipitated samples, and of input DNA. (A) Enrichment (RUNX1 antibody) of the MYL9-luciferase plasmid is observed from the cells transfected with Wt plasmid containing intact RUNX1 sites. This was abolished with mutations in any of the 4 RUNX1 sites. (B) As expected, Wt endogenous MYL9 sequence was amplified from chromatin immunoprecipitated by anti-RUNX1 antibody from all transfections, Wt or Mt. (C) GAPDH was not amplified from immunoprecipitated chromatin from any of the transfections.

Transient ChIP analysis using Wt and Mt MYL9 promoter (−691/+4)-luciferase reporter constructs in PMA-treated HEL cells. Cells were transfected with reporter constructs containing WtMYL9 promoter region (−691/+4) with RUNX1 sites (open boxes) or with RUNX1 sites I-IV individually mutated (filled boxes) as shown. ChIP was performed on these cells using anti-RUNX1 antibody or control IgG. PCR was performed using primers (shown by arrows), where the forward primer was specific to the MYL9 region (−140/−107) and the reverse primer was specific to the luciferase gene (Panel A; MYL9-luciferase plasmid). As a control, PCR was performed using a second set of primers (not shown) where both primers were specific to the endogenous MYL9 sequence (Panel B; endogenous MYL9). In addition, GAPDH was amplified (C). Each panel shows PCR products obtained from amplification of IgG- or anti-RUNX1 antibody-immunoprecipitated samples, and of input DNA. (A) Enrichment (RUNX1 antibody) of the MYL9-luciferase plasmid is observed from the cells transfected with Wt plasmid containing intact RUNX1 sites. This was abolished with mutations in any of the 4 RUNX1 sites. (B) As expected, Wt endogenous MYL9 sequence was amplified from chromatin immunoprecipitated by anti-RUNX1 antibody from all transfections, Wt or Mt. (C) GAPDH was not amplified from immunoprecipitated chromatin from any of the transfections.

Close Modal

or Create an Account

Close Modal
Close Modal